Structures by: Brunskill A. P.
Total: 55
Doravirine
C17H11ClF3N5O3
Molecular pharmaceutics (2020)
a=7.9899(5)Å b=10.1223(6)Å c=11.6441(7)Å
α=101.878(2)° β=104.712(2)° γ=97.380(2)°
Navarixin Ethanol Solvate
C21H23N3O5,C2H6O
Molecular pharmaceutics (2015) 12, 6 2061-2067
a=9.74560(10)Å b=10.05200(10)Å c=12.3150(2)Å
α=90° β=107.9123(3)° γ=90°
Navarixin methanol solvate
C21H23N3O5.CH4O
Molecular pharmaceutics (2015) 12, 6 2061-2067
a=9.4995(2)Å b=9.7624(2)Å c=12.7614(3)Å
α=90° β=111.6656(6)° γ=90°
4-bromo-2-isopropylphenol hemi-1,4-diazabicyclo[2.2.2]octane cocrystal
C9H11Br1O,0.5(C6H12N2)
Organic Process Research & Development (2020)
a=22.5044(8)Å b=8.2479(3)Å c=16.3708(6)Å
α=90° β=126.3250(11)° γ=90°
(+-)-2,3,3a,4,5,6-Hexahydro-7-methyl-1,12-dioxo-2,3a-propanophenalene
C17H18O2
Acta Crystallographica Section E (2006) 62, 1 o11-o12
a=7.9630(10)Å b=13.526(2)Å c=12.159(2)Å
α=90.00° β=96.240(10)° γ=90.00°
Santonic Acid
C15H20O4
Acta Crystallographica Section C (1999) 55, 4 566-568
a=7.7910(10)Å b=11.1980(10)Å c=16.986(2)Å
α=90.00° β=90.00° γ=90.00°
(+/-)-10a-Carboxy-1,9,10,10a-tetrahydrophenanthren-3(2H)-one
C15H14O3
Acta Crystallographica Section C (1999) 55, 4 563-566
a=9.305(2)Å b=12.780(3)Å c=10.444(3)Å
α=90.00° β=101.79(2)° γ=90.00°
(+-)-1-Indanone-2-acetic Acid
C11H10O3
Acta Crystallographica Section C (1999) 55, 4 568-572
a=8.9450(10)Å b=10.3180(10)Å c=10.1270(10)Å
α=90.00° β=96.400(10)° γ=90.00°
(+-)-1-Indanone-2-propionic Acid
C12H12O3
Acta Crystallographica Section C (1999) 55, 4 568-572
a=8.0930(10)Å b=8.3260(10)Å c=15.614(2)Å
α=90.00° β=96.200(10)° γ=90.00°
22,23-Bisnor-5α-cholanic acid-3-one
C22H34O3
Acta Crystallographica Section C (1998) 54, 3 421-424
a=12.433(2)Å b=6.6290(10)Å c=24.559(4)Å
α=90.00° β=93.380(10)° γ=90.00°
22,23-Bisnor-5α-cholanic acid-3-one Monohydrate
C22H36O4
Acta Crystallographica Section C (1998) 54, 3 421-424
a=12.696(3)Å b=6.168(2)Å c=26.784(7)Å
α=90.00° β=101.26(2)° γ=90.00°
(+\-)-3-indanone-1-acetic acid
C11H10O3
Acta Crystallographica Section C (1998) 54, 6 829-831
a=14.140(2)Å b=9.1670(10)Å c=7.2630(10)Å
α=90.00° β=90.00° γ=90.00°
3-oxo-1-cyclohexene-1-carboxylic acid
C7H8O3
Acta Crystallographica Section C (1998) 54, 9 1282-1285
a=9.7030(10)Å b=5.5820(10)Å c=12.7650(10)Å
α=90.00° β=97.900(10)° γ=90.00°
(+)-3-Oxoandrosta-1,4-diene-17β-carboxylic Acid
C20H26O3
Acta Crystallographica Section C (1999) 55, 10 1680-1682
a=6.5970(10)Å b=11.4680(10)Å c=11.1030(10)Å
α=90.00° β=91.900(10)° γ=90.00°
(+)-23,24-Dinor-3α,9α-epoxy-11-oxo-5β-cholan-22-oic Acid
C22H32O4
Acta Crystallographica Section C (1999) 55, 10 1677-1680
a=10.5880(10)Å b=12.5470(10)Å c=28.989(2)Å
α=90.00° β=90.00° γ=90.00°
(+)-cis-Pinonic Acid
C10H16O3
Acta Crystallographica Section C (1999) 55, 11 1908-1911
a=6.6250(10)Å b=11.4760(10)Å c=7.1270(10)Å
α=90.00° β=105.030(10)° γ=90.00°
(+)-4-Androsten-3-one-17β-carboxylic Acid
C20H28O3
Acta Crystallographica Section C (1997) 53, 7 903-906
a=6.9880(10)Å b=11.2540(10)Å c=11.480(2)Å
α=90.00° β=102.060(10)° γ=90.00°
2,4,5-trimethylbenzoic acid
C10H12O2
Acta Crystallographica Section C (1997) 53, 12 1842-1845
a=7.065(2)Å b=7.1990(10)Å c=9.726(2)Å
α=105.610(10)° β=103.460(10)° γ=99.610(10)°
(+\-)-3-Oxoindanecarboxylic Acid
C10H8O3
Acta Crystallographica Section C (1997) 53, 12 1838-1842
a=8.1510(10)Å b=13.426(2)Å c=8.344(2)Å
α=90.00° β=116.040(10)° γ=90.00°
(+\-)-3-Oxoindanecarboxylic Acid Monohydrate
C10H8O3,H2O1
Acta Crystallographica Section C (1997) 53, 12 1838-1842
a=5.9840(10)Å b=7.7630(10)Å c=11.0860(10)Å
α=107.290(10)° β=105.320(10)° γ=93.120(10)°
(+-)-exo3-Benzoylbicyclo[2.2.1]heptane-endo2-carboxylic acid
C15H16O3
Acta Crystallographica Section C (1999) 55, 11 1905-1908
a=7.646(2)Å b=10.799(4)Å c=15.446(5)Å
α=90.00° β=93.02(2)° γ=90.00°
(+-)-endo3-Benzoylbicyclo[2.2.1]heptane-endo2-carboxylic acid
C15H16O3
Acta Crystallographica Section C (1999) 55, 11 1905-1908
a=9.866(2)Å b=6.010(3)Å c=21.697(5)Å
α=90.00° β=99.580(10)° γ=90.00°
(+)-3-Oxoglycyrrhetinic acid
C30H44O4
Acta Crystallographica Section C (1999) 55, 11 1902-1905
a=7.3850(10)Å b=11.491(2)Å c=15.202(2)Å
α=90.00° β=101.940(10)° γ=90.00°
(+)-trans-Pinononic acid
C9H14O3
Acta Crystallographica Section C (1999) 55, 11 1899-1902
a=7.3872(9)Å b=9.6082(13)Å c=7.4972(14)Å
α=90.00° β=115.444(10)° γ=90.00°
(+/-)-4,5-Dihydro-1-oxo-2a(3H)-acenaphthylenecarboxylic acid
C13H12O3
Acta Crystallographica Section C (1997) 53, 5 599-601
a=6.7800(10)Å b=10.229(3)Å c=15.991(2)Å
α=90° β=98.83(2)° γ=90°
(+/-)-α-Tetralonecarboxylic Acid
C11H10O3
Acta Crystallographica Section C (1998) 54, 8 1180-1182
a=6.4046(9)Å b=5.2550(8)Å c=27.634(3)Å
α=90.00° β=92.111(8)° γ=90.00°
(+/-)-cis-10-Carboxymethyl-2-decalone
C12H18O3
Acta Crystallographica Section C (1998) 54, 11 1651-1653
a=9.182(2)Å b=10.917(2)Å c=21.955(4)Å
α=90.00° β=90.00° γ=90.00°
(+)-3-Oxo-5α-cholan-24-oic Acid
C24H38O3
Acta Crystallographica Section C (1999) 55, 3 419-422
a=10.458(2)Å b=7.619(2)Å c=13.280(2)Å
α=90.00° β=91.940(10)° γ=90.00°
(+-)-2-Aza-3,9-dioxotricyclo[4.4.4.0^1,6^]tetradecane
C13H19NO2
Acta Crystallographica Section C (1999) 55, 8 1370-1373
a=11.966(3)Å b=8.6020(10)Å c=23.688(3)Å
α=90.00° β=101.090(10)° γ=90.00°
(+-)-2-Aza-3,9-dioxotricyclo[4.4.4.0^1,6^]tetradecane
C13H19NO2
Acta Crystallographica Section C (1999) 55, 8 1370-1373
a=11.135(2)Å b=7.626(2)Å c=13.580(2)Å
α=90.00° β=90.620(10)° γ=90.00°
(+)-ketopinic acid
C10H14O3
Acta Crystallographica Section C (1999) 55, 9 1600-1605
a=7.3630(10)Å b=11.2990(10)Å c=23.502(3)Å
α=90.00° β=90.00° γ=90.00°
(+/-)-ketopinic acid
C10H14O3
Acta Crystallographica Section C (1999) 55, 9 1600-1605
a=7.0947(3)Å b=11.8316(6)Å c=12.1662(6)Å
α=72.0130(10)° β=77.0190(10)° γ=86.5460(10)°
(+-)-<i>trans</i>-3-Benzoylbicyclo[2.2.2]octane-2-carboxylic acid
C16H18O3
Acta Crystallographica Section E (2008) 64, 9 o1664
a=7.9155(7)Å b=11.1129(9)Å c=14.7559(12)Å
α=90.00° β=93.882(3)° γ=90.00°
[(+/-)-<i>cis</i>-8a-Hydroxy-2-oxoperhydronaphthalen-4a-yl]propanenitrile
C13H19NO2
Acta Crystallographica Section E (2007) 63, 2 o479-o481
a=5.8894(7)Å b=7.6197(11)Å c=13.4112(17)Å
α=91.860(7)° β=91.695(5)° γ=105.246(6)°
(+/-)-4-(2-Oxo-1,2,3,4,4a,5,6,7-octahydroquinolin-8-yl)butan-2-one
C13H19NO2
Acta Crystallographica Section E (2007) 63, 10 o4007-o4008
a=5.4984(2)Å b=10.4062(3)Å c=10.7217(3)Å
α=104.6939(11)° β=97.7636(14)° γ=91.1473(12)°
(+-)-3-Oxocyclopentanecarboxylic acid
C6H8O3
Acta Crystallographica Section C (2006) 62, 12 o669-o670
a=7.8564(8)Å b=7.9812(8)Å c=10.1367(10)Å
α=90.00° β=111.862(5)° γ=90.00°
(-)-3,6-Dioxo-5β-cholanic acid
C24H36O4,0.5H2O
Acta Crystallographica Section C (2001) 57, 5 632-633
a=13.144(3)Å b=7.750(2)Å c=22.415(5)Å
α=90.00° β=100.870(10)° γ=90.00°
(+-)-1-tetralone-2-acetic acid
C12H12O3
Acta Crystallographica Section C (2001) 57, 3 325-328
a=8.0008(10)Å b=10.579(2)Å c=12.6789(13)Å
α=90.00° β=105.616(8)° γ=90.00°
(+-)-1-tetralone-3-carboxylic acid
C11H10O3
Acta Crystallographica Section C (2001) 57, 3 325-328
a=6.2645(7)Å b=5.4440(12)Å c=26.170(3)Å
α=90.00° β=91.339(11)° γ=90.00°
7-Oxobicyclo[2.2.1]heptane-1-carboxylic acid
C8H10O3
Acta Crystallographica Section C (2000) 56, 3 371-373
a=6.3714(9)Å b=10.560(2)Å c=11.610(3)Å
α=90.00° β=98.616(14)° γ=90.00°
(+-)-7-oxobicyclo[2.2.1]hept-5-ene-2-endo-carboxylic acid
C8H8O3
Acta Crystallographica Section C (2000) 56, 3 371-373
a=6.0039(9)Å b=10.5565(14)Å c=22.151(2)Å
α=90.00° β=90.00° γ=90.00°
Cyclohexanone-3-carboxylic acid
C7H10O3
Acta Crystallographica Section C (2002) 58, 3 o154-o156
a=6.3346(17)Å b=10.758(3)Å c=11.012(3)Å
α=90.00° β=94.202(17)° γ=90.00°
Cyclohexanone-3-acetic acid
C8H12O3
Acta Crystallographica Section C (2002) 58, 3 o154-o156
a=6.625(2)Å b=5.6690(10)Å c=21.841(5)Å
α=90.00° β=90.33(2)° γ=90.00°
(-)-3-oxo-11α(H)-eudesm-4-en-12-oic acid
C15H22O3
Acta Crystallographica Section C (2002) 58, 5 o251-o253
a=10.0225(14)Å b=14.862(2)Å c=10.0873(14)Å
α=90.00° β=110.758(11)° γ=90.00°
(+-)-2,3,4,4a,5,6,7,8-Octahydro-2-oxonaphthalene-1-acetic acid monohydrate
C12H16O3,H2O
Acta Crystallographica Section C (2002) 58, 8 o491-o493
a=15.153(6)Å b=9.386(3)Å c=17.122(6)Å
α=90.00° β=93.629(14)° γ=90.00°
Phenylglyoxylic acid
C8H6O3
Acta Crystallographica Section C (2000) 56, 9 1148-1151
a=7.462(2)Å b=16.513(5)Å c=6.483(3)Å
α=90.00° β=115.32(2)° γ=90.00°
Mesitylglyoxylic acid
C11H12O3
Acta Crystallographica Section C (2000) 56, 9 1148-1151
a=9.1210(10)Å b=9.1210(10)Å c=10.5760(10)Å
α=90.00° β=90.00° γ=120.00°
4-Oxocyclohexanecarboxylic acid
C7H10O3,H2O
Acta Crystallographica Section C (2004) 60, 2 o140-o142
a=6.7298(8)Å b=7.2091(11)Å c=8.4367(12)Å
α=85.928(13)° β=83.075(17)° γ=82.132(16)°
5-oxocyclooctanecarboxylic acid
C9H14O3
Acta Crystallographica Section C (2000) 56, 10 1260-1262
a=6.7449(8)Å b=9.8755(13)Å c=13.878(2)Å
α=81.586(10)° β=86.189(10)° γ=88.519(9)°
(+)-Gibberellin C
C19H24O6,H2O
Acta Crystallographica Section C (2000) 56, 12 1507-1509
a=9.7300(10)Å b=10.661(2)Å c=17.898(3)Å
α=90.00° β=90.00° γ=90.00°
(-)-dioxosantadienic acid
C15H18O4
Acta Crystallographica Section C (2001) 57, 9 1075-1078
a=7.6790(10)Å b=14.644(2)Å c=12.4610(10)Å
α=90° β=96.430(10)° γ=90°
(-)-dioxosantadienic acid monohydrate
C15H18O4,H2O
Acta Crystallographica Section C (2001) 57, 9 1075-1078
a=8.7200(10)Å b=18.170(3)Å c=9.589(2)Å
α=90° β=100.13(2)° γ=90°
4-Oxocyclohexaneacetic acid
C8H12O3
Acta Crystallographica Section E (2010) 66, 10 o2576-o2577
a=6.8531(12)Å b=6.8531(12)Å c=17.372(3)Å
α=90.00° β=90.00° γ=90.00°
(η^2^,η^2^-Tetraphenylcyclopentadienone)-tricarbonyl-iron methylene chloride solvate
C32H20Fe1O4,C1H2Cl2
Journal of the American Chemical Society (2018) 140, 42 13843-13853
a=10.2420(2)Å b=11.6419(2)Å c=23.9124(5)Å
α=90° β=102.0253(10)° γ=90°
(1S,2R,4S,5R)-2-((S)-hydroxy(1-methylquinolin-1-ium-4-yl) methyl)-1-(4-nitrobenzyl)-5-vinylquinuclidin-1-ium Iodide Bromide Monohydrate
C27H33BrIN3O4
The Journal of organic chemistry (2017) 82, 16 8645-8650
a=12.2306(4)Å b=9.0943(3)Å c=13.4271(5)Å
α=90° β=114.0924(8)° γ=90°